PTPN1 and Hepatic fibrosis: Since AMPK inhibits HSC activation and PTP1B promotes it, FA’s ability to enhance AMPK activity and inhibit PTP1B suggests it effectively suppresses liver fibrosis progression through these combined mechanisms.